Skip to main content
OpenTrials
Completed

NCT Number: NCT00131170

Paravertebral Block for Breast Surgery

The effect of paravertebral block in combination with general anaesthesia is studied in a double blind fashion.

Completed

Looking for future studies?

Notify Me

Key information

Conditions

Breast Cancer Breast Diseases Breast Neoplasms Neoplasms Neoplasms by Site Skin Diseases Skin and Connective Tissue Diseases

Age range

18 year–85 year

Sex eligibility

Female

Study type

Interventional

Phase

Phase 4

Primary location

Dept of Anesthesiology, Aarhus University Hospital

Aarhus, DK 8000, Denmark

About this study

Patients having surgery for breast cancer receive a paravertebral blockade at C8-Th4 with either Naropin 0.5% or saline. General anaesthesia is then provided with laryngeal mask intubation, propofol infusion and fentanyl i.v. as needed. The effect on postoperative pain ([VAS] and fentanyl PCA doses taken) and postoperative nausea and vomiting is recorded.

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • Breast surgery

Exclusion criteria

  • Infections
  • Coagulation disorder
  • Allergy

Treatment and study plan

paravertebral block

Procedure

Primary outcomes

  1. Nausea and vomiting 2 hours postoperatively, and 1 and 2 days postoperatively

    Time frame: 2 days

Secondary outcomes

  1. Dosage of analgesic

    Time frame: 1 day

Sponsors and collaborators

Lead sponsor

University of Aarhus

Other

Registry information

Important dates

Study start
2005
Study completion
2006
First posted
Aug 17, 2005
Registry last updated
Jul 6, 2007

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Related clinical trials

Published trials that share one or more normalized conditions with this study.